Advanced search
Publication Cover
Molecular and Cellular Biology Volume 28, 2008 - Issue 19
Submit an article Journal homepage
27
Views
115
CrossRef citations to date
0
Altmetric
Article

The Forkhead Transcription Factor FOXO3a Increases Phosphoinositide-3 Kinase/Akt Activity in Drug-Resistant Leukemic Cells through Induction of PIK3CA Expression

Rosaline C.-Y. Hui1 Cancer Research-UK Labs, Department of Oncology, MRC Cyclotron Building, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, LondonW12 0NN, United Kingdom
,
Ana R. Gomes1 Cancer Research-UK Labs, Department of Oncology, MRC Cyclotron Building, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, LondonW12 0NN, United Kingdom
,
Demetra Constantinidou1 Cancer Research-UK Labs, Department of Oncology, MRC Cyclotron Building, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, LondonW12 0NN, United Kingdom
,
Joana R. Costa1 Cancer Research-UK Labs, Department of Oncology, MRC Cyclotron Building, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, LondonW12 0NN, United Kingdom
,
Christina T. Karadedou1 Cancer Research-UK Labs, Department of Oncology, MRC Cyclotron Building, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, LondonW12 0NN, United Kingdom
,
Silvia Fernandez de Mattos1 Cancer Research-UK Labs, Department of Oncology, MRC Cyclotron Building, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, LondonW12 0NN, United Kingdom
,
Matthias P. Wymann2 Department of Clinical and Biological Sciences, Institute of Biochemistry and Genetics, Centre of Biomedicine, University of Basel, Mattenstrasse 28, CH-4058Basel, Switzerland
,
Jan J. Brosens3 Institute of Reproductive and Developmental Biology, Hammersmith Hospital Campus, Du Cane Road, LondonW12 0NN, United Kingdom
,
Almut Schulze4 Gene Expression Analysis Laboratory, Cancer Research UK London Research Institute, 44 Lincoln's Inn Fields, LondonWC2A 3PX, United Kingdom
&
Eric W.-F. Lam1 Cancer Research-UK Labs, Department of Oncology, MRC Cyclotron Building, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, LondonW12 0NN, United KingdomCorrespondence[email protected]
 show all
Pages 5886-5898 | Received 15 Jul 2007, Accepted 13 Jul 2008, Published online: 27 Mar 2023

Citations (115)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jingyi Zhou, Wenjuan Liao, Jing Yang, Ke Ma, Xue Li, Yachen Wang, Donglai Wang, Lina Wang, Yu Zhang, Yuxin Yin, Ying Zhao & Wei-Guo Zhu. (2012) FOXO3 induces FOXO1-dependent autophagy by activating the AKT1 signaling pathway. Autophagy 8:12, pages 1712-1723.
Read now

Articles from other publishers (114)

Weiyingqi Cui, Ning Xie, Eric W.-F. Lam, Victoria Hahn-Stromberg, Na Liu, Hong Zhang & Xiao-Feng Sun. (2023) High expression of cytoplasmic FOXO3 protein associated with poor prognosis of rectal cancer patients: A study from Swedish clinical trial of preoperative radiotherapy to big database analysis. Heliyon 9:5, pages e15342.
Crossref
Mona Zidan, Abdel-Aziz A. Zidan, Mohamed Attia Saad, Mohamed El-Shanshory, Usama Bakry, Ashraf Sobh, Said Mohammed Abdou & Mohamed Labib Salem. (2023) Altered microRNA expression profile is linked to T-cell exhaustion-related pathways in pediatric patients with acute lymphoblastic leukemia. Human Immunology 84:2, pages 113-122.
Crossref
Archittapon Nokkeaw, Pannathon Thamjamrassri, Pisit Tangkijvanich & Chaiyaboot Ariyachet. (2023) Regulatory Functions and Mechanisms of Circular RNAs in Hepatic Stellate Cell Activation and Liver Fibrosis. Cells 12:3, pages 378.
Crossref
Shun Zhang, Xuan-Yu Zhou, Cheng Zhang, Chun-Pu Zhao, Wei Li, Dan-Li Wang & Shan-Liang Xu. (2022) Expression of the senescence-related gene FoxO in Daphnia pulex and its role in the regulation of reproductive transformation (Branchiopoda, Cladocera). Crustaceana 95:8-9, pages 961-983.
Crossref
Ying Liu, Yu Wang, Xiaoge Li, Yi Jia, Jianxun Wang & Xiang Ao. (2022) FOXO3a in cancer drug resistance. Cancer Letters 540, pages 215724.
Crossref
Yen-Sung Huang, Chang-Chieh Wu, Che-Chang Chang, Shiu-Feng Huang, Hong-Yi Kuo & Hsiu-Ming Shih. (2022) Reciprocal regulation of Daxx and PIK3CA promotes colorectal cancer cell growth. Cellular and Molecular Life Sciences 79:7.
Crossref
Shu Fang, Bo Peng, Yanan Wen, Jingjing Yang, Hao Wang, Ziwei Wang, Kun Qian, Yan Wei, Yifan Jiao, Chunji Gao & Liping Dou. (2022) Transcriptome-Wide Analysis of RNA N6-Methyladenosine Modification in Adriamycin-Resistant Acute Myeloid Leukemia Cells. Frontiers in Genetics 13.
Crossref
Xiaowei Guo, Zhuojie Li, Xiaojie Zhu, Meixiao Zhan, Chenxi Wu, Xiang Ding, Kai Peng, Wenzhe Li, Xianjue Ma, Zhongwei Lv, Ligong Lu & Lei Xue. (2022) A coherent FOXO3-SNAI2 feed-forward loop in autophagy. Proceedings of the National Academy of Sciences 119:11.
Crossref
Timothy A. Donlon, Randi Chen, Kamal H. Masaki, Bradley J. Willcox & Brian J. Morris. (2022) Association with Longevity of Phosphatidylinositol 3-Kinase Regulatory Subunit 1 Gene Variants Stems from Protection against Mortality Risk in Men with Cardiovascular Disease. Gerontology 68:2, pages 162-170.
Crossref
Kyoung Mi Moon, Min-Kyeong Lee, Taehyeok Hwang, Chun Whan Choi, Min Soo Kim, Hyeung-Rak Kim & Bonggi Lee. (2021) The multi-functional roles of forkhead box protein O in skin aging and diseases. Redox Biology 46, pages 102101.
Crossref
Milad Ghomlaghi, Anthony Hart, Nhan Hoang, Sungyoung Shin & Lan K. Nguyen. (2021) Feedback, Crosstalk and Competition: Ingredients for Emergent Non-Linear Behaviour in the PI3K/mTOR Signalling Network. International Journal of Molecular Sciences 22:13, pages 6944.
Crossref
Giuseppina Barrera, Marie Angele Cucci, Margherita Grattarola, Chiara Dianzani, Giuliana Muzio & Stefania Pizzimenti. (2021) Control of Oxidative Stress in Cancer Chemoresistance: Spotlight on Nrf2 Role. Antioxidants 10:4, pages 510.
Crossref
Giampaolo Calissi, Eric W.-F. Lam & Wolfgang Link. (2020) Therapeutic strategies targeting FOXO transcription factors. Nature Reviews Drug Discovery 20:1, pages 21-38.
Crossref
Neerajana Datta, Shrabastee Chakraborty, Malini Basu & Mrinal K. Ghosh. (2020) Tumor Suppressors Having Oncogenic Functions: The Double Agents. Cells 10:1, pages 46.
Crossref
Zhongyu Wang, Jun Shang, Zhiqin Li, Huanhuan Li, Chufan Zhang, Kai He, Shikang Li & Wen Ju. (2020) PIK3CA Is Regulated by CUX1, Promotes Cell Growth and Metastasis in Bladder Cancer via Activating Epithelial-Mesenchymal Transition. Frontiers in Oncology 10.
Crossref
Young San Ko, Nae Yu Kim & Jung-Soo Pyo. (2020) Clinicopathological significance and angiogenic role of the constitutive phosphorylation of the FOXO1 transcription factor in colorectal cancer. Pathology - Research and Practice 216:11, pages 153150.
Crossref
Mohd Farhan, Marta Silva, Shuai Li, Fengxia Yan, Jiankang Fang, Tangming Peng, Jim Hu, Ming‐Sound Tsao, Peter Little & Wenhua Zheng. (2020) The role of FOXOs and autophagy in cancer and metastasis—Implications in therapeutic development. Medicinal Research Reviews 40:6, pages 2089-2113.
Crossref
Timon A. Bloedjes, Guus de Wilde, Chiel Maas, Eric Eldering, Richard J. Bende, Carel J. M. van Noesel, Steven T. Pals, Marcel Spaargaren & Jeroen E. J. Guikema. (2020) AKT signaling restrains tumor suppressive functions of FOXO transcription factors and GSK3 kinase in multiple myeloma. Blood Advances 4:17, pages 4151-4164.
Crossref
Fangming Lin. (2020) Molecular regulation and function of FoxO3 in chronic kidney disease. Current Opinion in Nephrology & Hypertension 29:4, pages 439-445.
Crossref
Raúl Vivar, Claudio Humeres, Renatto Anfossi, Samir Bolivar, Mabel Catalán, Joseph Hill, Sergio Lavandero & Guillermo Diaz-Araya. (2020) Role of FoxO3a as a negative regulator of the cardiac myofibroblast conversion induced by TGF-β1. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1867:7, pages 118695.
Crossref
Rana Shafabakhsh, Hamed Mirzaei & Zatollah Asemi. (2019) Melatonin: A promising agent targeting leukemia. Journal of Cellular Biochemistry 121:4, pages 2730-2738.
Crossref
Mark Borris D. Aldonza, Jayoung Ku, Ji-Young Hong, Donghwa KimSeung Jung YuMin-Seok LeeMonica Celine PrayogoStephanie TanDayeon Kim, Jinju Han, Sang Kook Lee, Sung Gap Im, Han Suk RyuYoosik Kim. (2020) Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms. Science Advances 6:6.
Crossref
Stefan Salcher, Gilles Spoden, Judith Hagenbuchner, Sebastian Führer, Teresa Kaserer, Martin Tollinger, Petra Huber-Cantonati, Thomas Gruber, Daniela Schuster, Ronald Gust, Heinz Zwierzina, Thomas Müller, Ursula Kiechl-Kohlendorfer, Michael J. Ausserlechner & Petra Obexer. (2019) A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma. Oncogene 39:5, pages 1080-1097.
Crossref
Xinlei Gao, Yating Fu, Olugbenga Emmanuel Ajayi, Dongyang Guo, Liqin Zhang & Qingfa Wu. (2019) Identification of genes underlying phenotypic plasticity of wing size via insulin signaling pathway by network-based analysis in Sogatella furcifera. BMC Genomics 20:1.
Crossref
Fangming Liu, Haizhen Jin, Jinhong Shen, Dan Wu, Ye Tian & Chao Huang. (2019) Gp130 degradation induced by epirubicin contributes to chemotherapy efficacy. Biochemical and Biophysical Research Communications 519:3, pages 572-578.
Crossref
Yufeng Fu, Shuangyong Sun, Huijun Sun, Jinyong Peng, Xiaodong Ma, Liuchi Bao, Renpeng Ji, Chunxu Luo, Cong Gao, Xiaoxue Zhang & Yue Jin. (2019) Scutellarin exerts protective effects against atherosclerosis in rats by regulating the Hippo–FOXO3A and PI3K/AKT signaling pathways. Journal of Cellular Physiology 234:10, pages 18131-18145.
Crossref
Franziska Gehringer, Stephanie Weissinger, Lotteke Swier, Peter Möller, Thomas Wirth & Alexey Ushmorov. (2019) FOXO1 Confers Maintenance of the Dark Zone Proliferation and Survival Program and Can Be Pharmacologically Targeted in Burkitt Lymphoma. Cancers 11:10, pages 1427.
Crossref
Zimam Mahmud, Ana R. Gomes, Hee Jin Lee, Sathid Aimjongjun, Yannasittha Jiramongkol, Shang Yao, Stefania Zona, Glowi Alasiri, Gyungyub Gong, Ernesto Yagüe & Eric W.-F. Lam. (2019) EP300 and SIRT1/6 Co-Regulate Lapatinib Sensitivity Via Modulating FOXO3-Acetylation and Activity in Breast Cancer. Cancers 11:8, pages 1067.
Crossref
Michael G. Sugiyama, Gregory D. Fairn & Costin N. Antonescu. (2019) Akt-ing Up Just About Everywhere: Compartment-Specific Akt Activation and Function in Receptor Tyrosine Kinase Signaling. Frontiers in Cell and Developmental Biology 7.
Crossref
Herbert Sizek, Andrew Hamel, Dávid Deritei, Sarah Campbell & Erzsébet Ravasz Regan. (2019) Boolean model of growth signaling, cell cycle and apoptosis predicts the molecular mechanism of aberrant cell cycle progression driven by hyperactive PI3K. PLOS Computational Biology 15:3, pages e1006402.
Crossref
Meghan Riddell, Akiko Nakayama, Takao Hikita, Fatemeh Mirzapourshafiyi, Takuji Kawamura, Ayesha Pasha, Mengnan Li, Mikio Masuzawa, Mario Looso, Tim Steinbacher, Klaus Ebnet, Michael Potente, Tomonori Hirose, Shigeo Ohno, Ingrid Fleming, Stefan Gattenlöhner, Phyu P. Aung, Thuy Phung, Osamu Yamasaki, Teruki Yanagi, Hiroshi Umemura & Masanori Nakayama. (2018) aPKC controls endothelial growth by modulating c-Myc via FoxO1 DNA-binding ability. Nature Communications 9:1.
Crossref
Katharina Grupp, Faik Güntac Uzunoglu, Nathaniel Melling, Bianca Hofmann, Alexander Tarek El Gammal, Rainer Grotelüschen, Asmus Heumann, Eugen Bellon, Matthias Reeh, Gerrit Wolters-Eisfeld, Tarik Ghabdan, Michael Nentwich, Kai Bachmann, Maximillian Bockhorn, Dean Bogoevski, Jakob Robert Izbicki & Asad Kutup. (2018) FOXO1 overexpression and loss of pSerine256-FOXO1 expression predicts clinical outcome in esophageal adenocarcinomas. Scientific Reports 8:1.
Crossref
Raj Kumar Yadav, Anoop Singh Chauhan, Li Zhuang & Boyi Gan. (2018) FoxO transcription factors in cancer metabolism. Seminars in Cancer Biology 50, pages 65-76.
Crossref
M. Hornsveld, T.B. Dansen, P.W. Derksen & B.M.T. Burgering. (2018) Re-evaluating the role of FOXOs in cancer. Seminars in Cancer Biology 50, pages 90-100.
Crossref
Alexey Ushmorov & Thomas Wirth. (2018) FOXO in B-cell lymphopoiesis and B cell neoplasia. Seminars in Cancer Biology 50, pages 132-141.
Crossref
Mohammad Mohajeri & Amirhossein Sahebkar. (2018) Protective effects of curcumin against doxorubicin-induced toxicity and resistance: A review. Critical Reviews in Oncology/Hematology 122, pages 30-51.
Crossref
Mei-Qin Zhuo, Zhi Luo, Yi-Huan Xu, Dan-Dan Li, Ya-Xiong Pan & Kun Wu. (2018) Functional Analysis of Promoters from Three Subtypes of the PI3K Family and Their Roles in the Regulation of Lipid Metabolism by Insulin in Yellow Catfish Pelteobagrus fulvidraco. International Journal of Molecular Sciences 19:1, pages 265.
Crossref
Sabina van Doeselaar & Boudewijn M.T. Burgering. 2018. Forkhead FOXO Transcription Factors in Development and Disease. Forkhead FOXO Transcription Factors in Development and Disease 49 103 .
Jin Zhang, Xuemei Zhang, Yingjie Liu, Zihao Su, Farman Ullah Dawar, Hong Dan, Yan He, Jian-Fang Gui & Jie Mei. (2017) Leucine mediates autophagosome-lysosome fusion and improves sperm motility by activating the PI3K/Akt pathway. Oncotarget 8:67, pages 111807-111818.
Crossref
Wolfgang Link & Pablo J. Fernandez-Marcos. (2017) FOXO transcription factors at the interface of metabolism and cancer. International Journal of Cancer 141:12, pages 2379-2391.
Crossref
M Rupp, J Hagenbuchner, B Rass, H Fiegl, U Kiechl-Kohlendorfer, P Obexer & M J Ausserlechner. (2017) FOXO3-mediated chemo-protection in high-stage neuroblastoma depends on wild-type TP53 and SESN3. Oncogene 36:44, pages 6190-6203.
Crossref
Nicholas J. Monteleone & Carol S. Lutz. (2017) miR-708-5p: a microRNA with emerging roles in cancer. Oncotarget 8:41, pages 71292-71316.
Crossref
Li Wang, Zhaofei Ni, Yujie Liu, Shuang Ji, Fuquan Jin, Keguo Jiang, Junfang Ma, Cuiping Ren, Hongbing Zhang, Zhongdong Hu & Xiaojun Zha. (2017) Hyperactivated mTORC1 downregulation of FOXO3a/PDGFRα/AKT cascade restrains tuberous sclerosis complex-associated tumor development. Oncotarget 8:33, pages 54858-54872.
Crossref
David G. Covell. (2017) A data mining approach for identifying pathway-gene biomarkers for predicting clinical outcome: A case study of erlotinib and sorafenib. PLOS ONE 12:8, pages e0181991.
Crossref
Raj Pranap Arun, Divya Sivanesan, Prasanna Vidyasekar & Rama Shanker Verma. (2017) PTEN/FOXO3/AKT pathway regulates cell death and mediates morphogenetic differentiation of Colorectal Cancer Cells under Simulated Microgravity. Scientific Reports 7:1.
Crossref
Zhongrun Qian, Li Ren, Dingchang Wu, Xi Yang, Zhiyi Zhou, Quanmin Nie, Gan Jiang, Shuanglin Xue, Weiji Weng, Yongming Qiu & Yingying Lin. (2017) Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis. International Journal of Cancer 140:12, pages 2792-2804.
Crossref
Mark Borris D Aldonza, Ji-Young Hong & Sang Kook Lee. (2017) Paclitaxel-resistant cancer cell-derived secretomes elicit ABCB1-associated docetaxel cross-resistance and escape from apoptosis through FOXO3a-driven glycolytic regulation. Experimental & Molecular Medicine 49:1, pages e286-e286.
Crossref
Fengxia Yan, Rifang Liao, Mohd Farhan, Tinghuai Wang, Jiashu Chen, Zhong Wang, Peter J. Little & Wenhua Zheng. (2016) Elucidating the role of the FoxO3a transcription factor in the IGF-1-induced migration and invasion of uveal melanoma cancer cells. Biomedicine & Pharmacotherapy 84, pages 1538-1550.
Crossref
Judith Hagenbuchner, Martina Rupp, Christina Salvador, Bernhard Meister, Ursula Kiechl-Kohlendorfer, Thomas Müller, Kathrin Geiger, Consolato Sergi, Petra Obexer & Michael J. Ausserlechner. (2016) Nuclear FOXO3 predicts adverse clinical outcome and promotes tumor angiogenesis in neuroblastoma. Oncotarget 7:47, pages 77591-77606.
Crossref
Bhushan Thakur & Pritha Ray. (2016) p53 Loses grip on PIK3CA expression leading to enhanced cell survival during platinum resistance. Molecular Oncology 10:8, pages 1283-1295.
Crossref
M Wagle, A M Eiring, M Wongchenko, S Lu, Y Guan, Y Wang, M Lackner, L Amler, G Hampton, M W Deininger, T O'Hare & Y Yan. (2016) A role for FOXO1 in BCR–ABL1-independent tyrosine kinase inhibitor resistance in chronic myeloid leukemia. Leukemia 30:7, pages 1493-1501.
Crossref
Alexandra Coomans de Brachène & Jean-Baptiste Demoulin. (2015) FOXO transcription factors in cancer development and therapy. Cellular and Molecular Life Sciences 73:6, pages 1159-1172.
Crossref
Josiah Cox & Steven Weinman. (2016) Mechanisms of doxorubicin resistance in hepatocellular carcinoma. Hepatic Oncology 3:1, pages 57-59.
Crossref
Guili Zhang, Fei Dong, Caifu Luan, Xia Zhang, Huiyuan Shao, Jie Liu & Chengming Sun. (2016) Overexpression of CCAAT Enhancer-Binding Protein α Inhibits the Growth of K562 Cells via the Foxo3a-Bim Pathway. Acta Haematologica 136:2, pages 65-70.
Crossref
Charles B Goodwin & Rebecca J. Chan. 2016. PI3K-mTOR in Cancer and Cancer Therapy. PI3K-mTOR in Cancer and Cancer Therapy 181 229 .
Yuki Nishida, Aya Maeda, Dhruv Chachad, Jo Ishizawa, Yi Hua Qiu, Steven M. Kornblau, Shinya Kimura, Michael Andreeff & Kensuke Kojima. (2015) Preclinical activity of the novel B‐cell‐specific Moloney murine leukemia virus integration site 1 inhibitor PTC ‐209 in acute myeloid leukemia: Implications for leukemia therapy . Cancer Science 106:12, pages 1705-1713.
Crossref
FRANCESCA CONSOLARO, GIUSEPPE BASSO, SADAF GHAEM-MAGAMI, ERIC W.-F. LAM & GIAMPIETRO VIOLA. (2015) FOXM1 is overexpressed in B-acute lymphoblastic leukemia (B-ALL) and its inhibition sensitizes B-ALL cells to chemotherapeutic drugs. International Journal of Oncology 47:4, pages 1230-1240.
Crossref
L-H Zhang, A-A Yin, J-X Cheng, H-Y Huang, X-M Li, Y-Q Zhang, N Han & X Zhang. (2014) TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway. Oncogene 34:5, pages 600-610.
Crossref
Brian J. Morris, Donald Craig Willcox, Timothy A. Donlon & Bradley J. Willcox. (2015) <b><i>FOXO3:</i></b> A Major Gene for Human Longevity - A Mini-Review. Gerontology 61:6, pages 515-525.
Crossref
Wei Huang, Qun-dan Wu, Min Zhang, Ying-li Kong, Pin-rong Cao, Wei Zheng, Jian-hua Xu & Min Ye. (2015) Novel Hsp90 inhibitor FW-04-806 displays potent antitumor effects in HER2-positive breast cancer cells as a single agent or in combination with lapatinib. Cancer Letters 356:2, pages 862-871.
Crossref
Mafalda Videira, Rita Leones Reis & Maria Alexandra Brito. (2014) Deconstructing breast cancer cell biology and the mechanisms of multidrug resistance. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1846:2, pages 312-325.
Crossref
HONG ZHU. (2014) Targeting forkhead box transcription factors FOXM1 and FOXO in leukemia (Review). Oncology Reports 32:4, pages 1327-1334.
Crossref
Da-Ae Yu, Jiyeon Yoon, Young San Ko, Jinju Park, Sue Youn Kim, Min A Kim, Ji Hun Kim, Jieun Jung, Younghee Cheon, Hye Seung Lee, Woo Ho Kim & Byung Lan Lee. (2014) Forkhead transcription factor FOXO1 inhibits nuclear factor-κB in gastric cancer. APMIS 122:9, pages 848-855.
Crossref
S S Myatt, M Kongsema, C W-Y Man, D J Kelly, A R Gomes, P Khongkow, U Karunarathna, S Zona, J K Langer, C W Dunsby, R C Coombes, P M French, J J Brosens & E W-F Lam. (2013) SUMOylation inhibits FOXM1 activity and delays mitotic transition. Oncogene 33:34, pages 4316-4329.
Crossref
Jose AramburuM. Carmen OrtellsSonia TejedorMaria BuxadéCristina López-Rodríguez. (2014) Transcriptional regulation of the stress response by mTOR. Science Signaling 7:332.
Crossref
Jangsoon Lee, Chandra Bartholomeusz, Oula Mansour, Juliane Humphries, Gabriel N. Hortobagyi, Peter Ordentlich & Naoto T. Ueno. (2014) A class I histone deacetylase inhibitor, entinostat, enhances lapatinib efficacy in HER2-overexpressing breast cancer cells through FOXO3-mediated Bim1 expression. Breast Cancer Research and Treatment 146:2, pages 259-272.
Crossref
Jinju Park, Young San Ko, Jiyeon Yoon, Min A. Kim, Jong-Wan Park, Woo Ho Kim, Youngsun Choi, Ji Hun Kim, Younghee Cheon & Byung Lan Lee. (2013) The forkhead transcription factor FOXO1 mediates cisplatin resistance in gastric cancer cells by activating phosphoinositide 3-kinase/Akt pathway. Gastric Cancer 17:3, pages 423-430.
Crossref
Yu Wang, Yanmin Zhou & Dana T. Graves. (2014) FOXO Transcription Factors: Their Clinical Significance and Regulation. BioMed Research International 2014, pages 1-13.
Crossref
Eric W.-F. Lam, Kyle W. Muir & Chuay-Yeng Koo. 2015. Molecular Oncology. Molecular Oncology 328 335 .
Kevin D. Courtney & Lewis C. Cantley. 2015. Molecular Oncology. Molecular Oncology 218 230 .
Yaoyu Chen & Shaoguang Li. (2013) Molecular signatures of chronic myeloid leukemia stem cells. Biomarker Research 1:1.
Crossref
R van Boxtel, C Gomez-Puerto, M Mokry, A Eijkelenboom, K E van der Vos, E ES Nieuwenhuis, B MT Burgering, E W -F Lam & P J Coffer. (2013) FOXP1 acts through a negative feedback loop to suppress FOXO-induced apoptosis. Cell Death & Differentiation 20:9, pages 1219-1229.
Crossref
Eric W.-F. Lam, Jan J. Brosens, Ana R. Gomes & Chuay-Yeng Koo. (2013) Forkhead box proteins: tuning forks for transcriptional harmony. Nature Reviews Cancer 13:7, pages 482-495.
Crossref
Evan E. Santo, Peter Stroeken, Peter V. Sluis, Jan Koster, Rogier Versteeg & Ellen M. Westerhout. (2013) FOXO3a Is a Major Target of Inactivation by PI3K/AKT Signaling in Aggressive Neuroblastoma. Cancer Research 73:7, pages 2189-2198.
Crossref
Astrid Eijkelenboom & Boudewijn M. T. Burgering. (2013) FOXOs: signalling integrators for homeostasis maintenance. Nature Reviews Molecular Cell Biology 14:2, pages 83-97.
Crossref
Azusa Abe, Takeo Minaguchi, Hiroyuki Ochi, Mamiko Onuki, Satoshi Okada, Koji Matsumoto, Toyomi Satoh, Akinori Oki & Hiroyuki Yoshikawa. (2013) PIK3CA overexpression is a possible prognostic factor for favorable survival in ovarian clear cell carcinoma. Human Pathology 44:2, pages 199-207.
Crossref
Jonathan T. Sims, Sourik S. Ganguly, Holly Bennett, J. Woodrow Friend, Jessica Tepe & Rina Plattner. (2013) Imatinib Reverses Doxorubicin Resistance by Affecting Activation of STAT3-Dependent NF-κB and HSP27/p38/AKT Pathways and by Inhibiting ABCB1. PLoS ONE 8:1, pages e55509.
Crossref
Ronit Vogt Sionov. (2013) MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies. ISRN Hematology 2013, pages 1-58.
Crossref
Astrid Eijkelenboom, Michal Mokry, Elzo de Wit, Lydia M Smits, Paulien E Polderman, Miranda H van Triest, Ruben van Boxtel, Almut Schulze, Wouter de Laat, Edwin Cuppen & Boudewijn M T Burgering. (2013) Genome‐wide analysis of FOXO3 mediated transcription regulation through RNA polymerase II profiling. Molecular Systems Biology 9:1.
Crossref
Fung Zhao & Eric W. -F. Lam. (2012) Role of the forkhead transcription factor FOXO-FOXM1 axis in cancer and drug resistance. Frontiers of Medicine 6:4, pages 376-380.
Crossref
H Salim, N S Akbar, D Zong, A H Vaculova, R Lewensohn, A Moshfegh, K Viktorsson & B Zhivotovsky. (2012) miRNA-214 modulates radiotherapy response of non-small cell lung cancer cells through regulation of p38MAPK, apoptosis and senescence. British Journal of Cancer 107:8, pages 1361-1373.
Crossref
Qingbo Lang & Changquan Ling. (2012) MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA. Biochemical and Biophysical Research Communications 426:2, pages 247-252.
Crossref
Timothy A. Yap, Mike I. Walton, Kyla M. Grimshaw, Robert H. te Poele, Paul D. Eve, Melanie R. Valenti, Alexis K. de Haven Brandon, Vanessa Martins, Anna Zetterlund, Simon P. Heaton, Kathrin Heinzmann, Paul S. Jones, Ruth E. Feltell, Matthias Reule, Steven J. Woodhead, Thomas G. Davies, John F. Lyons, Florence I. Raynaud, Suzanne A. Eccles, Paul Workman, Neil T. Thompson & Michelle D. Garrett. (2012) AT13148 Is a Novel, Oral Multi-AGC Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity. Clinical Cancer Research 18:14, pages 3912-3923.
Crossref
Masaki Shiota, Ario Takeuchi, Akira Yokomizo, Eiji Kashiwagi, Katsunori Tatsugami, Kentaro Kuroiwa & Seiji Naito. (2012) Androgen Receptor Signaling Regulates Cell Growth and Vulnerability to Doxorubicin in Bladder Cancer. Journal of Urology 188:1, pages 276-286.
Crossref
Zhaodong Li, Haisheng Zhang, Ying Chen, Li Fan & Jing Fang. (2012) Forkhead Transcription Factor FOXO3a Protein Activates Nuclear Factor κB through B-cell lymphoma/leukemia 10 (BCL10) Protein and Promotes Tumor Cell Survival in Serum Deprivation. Journal of Biological Chemistry 287:21, pages 17737-17745.
Crossref
Gabriela Nestal de Moraes, Paloma Silva Souza, Fernanda Casal de Faria Costas, Flavia Cunha Vasconcelos, Flaviana Ruade Souza Reis & Raquel Ciuvalschi Maia. (2012) The Interface between BCR-ABL-Dependent and -Independent Resistance Signaling Pathways in Chronic Myeloid Leukemia. Leukemia Research and Treatment 2012, pages 1-19.
Crossref
C T Karadedou, A R Gomes, J Chen, M Petkovic, K-K Ho, A K Zwolinska, A Feltes, S Y Wong, K Y K Chan, Y-N Cheung, J W H Tsang, J J Brosens, U-S Khoo & E W-F Lam. (2011) FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer. Oncogene 31:14, pages 1845-1858.
Crossref
Roel Polak & Miranda Buitenhuis. (2012) The PI3K/PKB signaling module as key regulator of hematopoiesis: implications for therapeutic strategies in leukemia. Blood 119:4, pages 911-923.
Crossref
Eric W-F Lam, Kunal Shah & Jan J Brosens. (2012) The diversity of sex steroid action: the role of micro-RNAs and FOXO transcription factors in cycling endometrium and cancer. Journal of Endocrinology 212:1, pages 13-25.
Crossref
Ka-Kei Ho, Victoria A. McGuire, Chuay-Yeng Koo, Kyle W. Muir, Natalia de Olano, Evie Maifoshie, Douglas J. Kelly, Ursula B. McGovern, Lara J. Monteiro, Ana R. Gomes, Angel R. Nebreda, David G. Campbell, J. Simon C. Arthur & Eric W.-F. Lam. (2012) Phosphorylation of FOXO3a on Ser-7 by p38 Promotes Its Nuclear Localization in Response to Doxorubicin. Journal of Biological Chemistry 287:2, pages 1545-1555.
Crossref
Chuay-Yeng Koo, Kyle W. Muir & Eric W.-F. Lam. (2012) FOXM1: From cancer initiation to progression and treatment. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1819:1, pages 28-37.
Crossref
Bo-Wei Han, Dan-Dan Feng, Zhi-Gang Li, Xue-Qun Luo, Hua Zhang, Xiao-Juan Li, Xing-Ju Zhang, Ling-Ling Zheng, Cheng-Wu Zeng, Kang-Yu Lin, Peng Zhang, Ling Xu & Yue-Qin Chen. (2011) A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL. Human Molecular Genetics 20:24, pages 4903-4915.
Crossref
David E.A. Kloet & Boudewijn M.T. Burgering. (2011) The PKB/FOXO switch in aging and cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1813:11, pages 1926-1937.
Crossref
James A. McCubrey, Linda S. Steelman, C. Ruth Kempf, William H. Chappell, Stephen L. Abrams, Franca Stivala, Graziella Malaponte, Ferdinando Nicoletti, Massimo Libra, Jörg Bäsecke, Danijela Maksimovic-Ivanic, Sanja Mijatovic, Giuseppe Montalto, Melchiorre Cervello, Lucio Cocco & Alberto M. Martelli. (2011) Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways. Journal of Cellular Physiology 226:11, pages 2762-2781.
Crossref
A M Martelli, C Evangelisti, W Chappell, S L Abrams, J Bäsecke, F Stivala, M Donia, P Fagone, F Nicoletti, M Libra, V Ruvolo, P Ruvolo, C R Kempf, L S Steelman & J A McCubrey. (2011) Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway. Leukemia 25:7, pages 1064-1079.
Crossref
Jung-Chien Cheng & Peter C.K. Leung. (2011) Type I collagen down-regulates E-cadherin expression by increasing PI3KCA in cancer cells. Cancer Letters 304:2, pages 107-116.
Crossref
Daisuke Ikegami, Haruhiko Akiyama, Akira Suzuki, Takashi Nakamura, Toru Nakano, Hideki Yoshikawa & Noriyuki Tsumaki. (2011) Sox9 sustains chondrocyte survival and hypertrophy in part through Pik3ca-Akt pathways. Development 138:8, pages 1507-1519.
Crossref
Kristan E. van der VosPaul J. Coffer. (2011) The Extending Network of FOXO Transcriptional Target Genes. Antioxidants & Redox Signaling 14:4, pages 579-592.
Crossref
Stephen S. MyattJan J. BrosensEric W.-F. Lam. (2011) Sense and Sensitivity: FOXO and ROS in Cancer Development and Treatment. Antioxidants & Redox Signaling 14:4, pages 675-687.
Crossref
Yolanda Olmos, Jan J. Brosens & Eric W.-F. Lam. (2011) Interplay between SIRT proteins and tumour suppressor transcription factors in chemotherapeutic resistance of cancer. Drug Resistance Updates 14:1, pages 35-44.
Crossref
Melissa Dobson & Guri Tzivion. (2011) Foxo3. AfCS-Nature Molecule Pages.
Crossref
Kou Peng, Yi Li, Ling Long, Dong Li, Qiuli Jia, Yidong Wang, Qingyu Shen, Yamei Tang, Lu Wen, Hsiang-fu Kung & Ying Peng. (2010) Knockdown of FoxO3a induces increased neuronal apoptosis during embryonic development in zebrafish. Neuroscience Letters 484:2, pages 98-103.
Crossref
Jie Chen, Ana R. Gomes, Lara J. Monteiro, San Yu Wong, Lai Han Wu, Ting-Ting Ng, Christina T. Karadedou, Julie Millour, Ying-Chi Ip, Yuen Nei Cheung, Andrew Sunters, Kelvin Y. K. Chan, Eric W.-F. Lam & Ui-Soon Khoo. (2010) Constitutively Nuclear FOXO3a Localization Predicts Poor Survival and Promotes Akt Phosphorylation in Breast Cancer. PLoS ONE 5:8, pages e12293.
Crossref
Steven M. Kornblau, Neera Singh, YiHua Qiu, Wenjing Chen, Nianxiang Zhang & Kevin R. Coombes. (2010) Highly Phosphorylated FOXO3A Is an Adverse Prognostic Factor in Acute Myeloid Leukemia. Clinical Cancer Research 16:6, pages 1865-1874.
Crossref
James M. Cleary & Geoffrey I. Shapiro. (2010) Development of Phosphoinositide-3 Kinase Pathway Inhibitors for Advanced Cancer. Current Oncology Reports 12:2, pages 87-94.
Crossref
Stephen S. Myatt, Jun Wang, Lara J. Monteiro, Mark Christian, Ka-Kei Ho, Luca Fusi, Roberto E. Dina, Jan J. Brosens, Sadaf Ghaem-Maghami & Eric W-F. Lam. (2010) Definition of microRNAs That Repress Expression of the Tumor Suppressor Gene FOXO1 in Endometrial Cancer . Cancer Research 70:1, pages 367-377.
Crossref
Yanli He, Jine Zheng, Yanjie Hu, Hong Xiao, Jun Liu, Xiaoqing Li, Wen Du, Xiangjun Chen, Yu Hu & Shiang Huang. (2010) Chronic myeloid leukemia and BCR/ABL signal pathways are not associated with AKT1 pleckstrin homology domain (E17K) mutations. European Journal of Haematology 84:1, pages 87-88.
Crossref
Guylène FiraguayJacques A. Nunès. (2009) Analysis of Signaling Events by Dynamic Phosphoflow Cytometry. Science Signaling 2:86.
Crossref
Xiujuan Qu, Ye Zhang, Yingchun Li, Xuejun Hu, Yingying Xu, Ling Xu, Kezou Hou, Kiyonao Sada & Yunpeng Liu. (2009) Ubiquitin ligase Cbl-b sensitizes leukemia and gastric cancer cells to anthracyclines by activating the mitochondrial pathway and modulating Akt and ERK survival signals. FEBS Letters 583:13, pages 2255-2262.
Crossref
A Astanehe, M R Finkbeiner, P Hojabrpour, K To, A Fotovati, A Shadeo, A L Stratford, W L Lam, I M Berquin, V Duronio & S E Dunn. (2009) The transcriptional induction of PIK3CA in tumor cells is dependent on the oncoprotein Y-box binding protein-1. Oncogene 28:25, pages 2406-2418.
Crossref
Klaartje Kok, Barbara Geering & Bart Vanhaesebroeck. (2009) Regulation of phosphoinositide 3-kinase expression in health and disease. Trends in Biochemical Sciences 34:3, pages 115-127.
Crossref
Wei-Chien Huang & Mien-Chie Hung. (2009) Induction of Akt Activity by Chemotherapy Confers Acquired Resistance. Journal of the Formosan Medical Association 108:3, pages 180-194.
Crossref
Jan J. Brosens, Miranda S. C. Wilson & Eric W. -F. Lam. 2010. Forkhead Transcription Factors. Forkhead Transcription Factors 227 241 .
Weiyingqi Cui, Ning Xie, Eric W-F Lam, Victoria Hahn-Stromberg, Na Liu, Hong Zhang & Xiao-Feng Sun. (2022) High Cytoplasmic FOXO3 Expression Associated with Poor Prognosis in Rectal Cancer Patients Received Preoperative Radiotherapy: A Study from Swedish Clinical Trial of Preoperative Radiotherapy to Big Database Analysis. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.